XML 31 R20.htm IDEA: XBRL DOCUMENT v3.25.1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2025
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Amy L. Ladd, M.D. [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On January 29, 2025, Amy L. Ladd, M.D., a member of the Company’s Board of Directors, adopted a Rule 10b5-1 trading plan. Dr. Ladd’s trading plan provides for the potential exercise and sale of up to 8,776 shares of the Company’s common stock subject to stock options until January 29, 2026. This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and the Company’s policies regarding transactions in the Company’s securities.
Name Amy L. Ladd, M.D.
Title member of the Company’s Board of Directors
Rule 10b5-1 Arrangement Adopted true
Adoption Date January 29, 2025
Expiration Date January 29, 2026
Arrangement Duration 365 days
Aggregate Available 8,776
Amal M. Johnson [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On January 31, 2025, Amal M. Johnson, a member of the Company’s Board of Directors, adopted a Rule 10b5-1 trading plan. Ms. Johnson’s trading plan provides for the potential exercise and sale of up to 5,346 shares of the Company’s common stock subject to stock options until March 13, 2026. This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and the Company’s policies regarding transactions in the Company’s securities.
Name Amal M. Johnson
Title member of the Company’s Board of Directors
Rule 10b5-1 Arrangement Adopted true
Adoption Date January 31, 2025
Expiration Date March 13, 2026
Arrangement Duration 406 days
Aggregate Available 5,346